Cargando…
Evaluation of Abbott ID NOW COVID-19 POC test performance characteristics and integration in the regional health network workflows to improve health care delivery
With the recent global surge of SARS-CoV-2 Delta variant, there continues to be high demand for COVID-19 diagnostic testing. Abbott ID NOW is a rapid, CLIA-waived, COVID-19 diagnostic test ideally suited for use in urgent care settings or where access to diagnostic testing is limited. In this study...
Autores principales: | Babic, N., Garner, K.S., Hirschhorn, J.W., Zebian, R., Nolte, F.S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Canadian Society of Clinical Chemists. Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653396/ https://www.ncbi.nlm.nih.gov/pubmed/34896098 http://dx.doi.org/10.1016/j.clinbiochem.2021.12.003 |
Ejemplares similares
-
Abbott ID NOW™ COVID-19 assay: do not discard the swab
por: MacDonald, Clayton, et al.
Publicado: (2023) -
Abbott ID now COVID-19 assay performance: a year in review
por: Thwe, Phyu M., et al.
Publicado: (2021) -
Evaluating the Ability to ID (COVID-19) NOW: a Large Real-World Prospective Evaluation of the Abbott ID NOW COVID-19 Assay
por: Barker, K. R., et al.
Publicado: (2022) -
Acceptable performance of the Abbott ID NOW among symptomatic individuals with confirmed COVID-19
por: Stokes, William, et al.
Publicado: (2021) -
Comparison of Abbott ID Now and Abbott m2000 Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Symptomatic Patients
por: Harrington, Amanda, et al.
Publicado: (2020)